The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
Secretary Robert F. Kennedy Jr. has made waves during his first week in office, pulling promotional vaccine ads and ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
At two Senate confirmation hearings, Kennedy played down his well-publicised questioning of the safety of childhood vaccines ...
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...